Miami Heart Research Institute

Recent papers from Miami Heart Research Institute

1. Historical Baseline Electrocardiogram Ascertainment Prior to Cancer Diagnosis and Cardiovascular Diagnosis Patterns in Cancer Survivors: A Retrospective Observational Cohort StudyCancers · 2026
2. MPLA case: A proposal for purchasing SRS/SBRT QA equipmentJournal of Applied Clinical Medical Physics · 2026
3. The Transaortic Approach for Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology · 2013
4. Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2Journal of Clinical Oncology · 2026
5. Fibrinogen: a predictor of stroke and marker of atherosclerosisEuropean Heart Journal · 2003
6. Stereotactic radiotherapy for rib metastases from prostate cancer: A multicenter real-world analysis of local control, pain response, and treatment tolerance (RIBRISK)Therapeutic Advances in Medical Oncology · 2026
7. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST)Journal of the American College of Cardiology · 2004
8. Have we Made Progress in Ensuring Equitable Penetration of TAVR Among Diverse Patient Populations? If not, Why?Current Cardiovascular Risk Reports · 2026
9. Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp TrialInternational Journal of Radiation Oncology*Biology*Physics · 2026
10. Targeting the cGAS–STING pathway mitigates Huntington disease pathogenesis in a knock-in mouse modelProceedings of the National Academy of Sciences · 2026
11. Renal safety and clinical outcomes of enfortumab vedotin plus pembrolizumab in urothelial carcinoma patients with chronic kidney disease.Journal of Clinical Oncology · 2026
12. A quality improvement initiative to improve genomic testing rates in patients with prostate cancer.Journal of Clinical Oncology · 2026
13. Global mortality and disability burden of young-onset non-colorectal gastrointestinal cancers, 1990–2021.Journal of Clinical Oncology · 2026
14. Intracranial efficacy of osimertinib in EGFR -mutated non–small cell lung cancer with brain metastases: A meta-analysis.Journal of Clinical Oncology · 2026
15. PD-1 inhibitor plus VEGFR-2 inhibitor and chemotherapy versus chemotherapy alone for locally advanced gastric cancer: A systematic review and meta-analysis.Journal of Clinical Oncology · 2026
16. Patterns of cause of death among patients with subsequent primary malignancies after cutaneous melanoma: A SEER-based analysis (2000–2022).Journal of Clinical Oncology · 2026
17. Trends in hypofractionation, stereotactic body radiotherapy, metastatic radiotherapy utilization, and plan pricing at a tertiary cancer center: A plan-level analysis (2018–2024).Journal of Clinical Oncology · 2026
18. Efficacy and safety of antibody-drug conjugates in gastrointestinal malignancies: A systematic review and meta-analysis of phase I-III trials.Journal of Clinical Oncology · 2026
19. Impact of cirrhosis on the metabolic profile, tumor presentation, and management of MASLD-associated hepatocellular carcinoma: A systematic review and meta-analysis.Journal of Clinical Oncology · 2026
20. A systematic review and meta-analysis on safety and efficacy of Lu-177 PSMA-617 and standardized treatment in mCRPC from randomized phase II/III trials.Journal of Clinical Oncology · 2026